[Symptomatic effect of epomediol in patients with cholestasis of pregnancy].
González M, Iglesias J, Tiribelli C, Ribalta J, Reyes H, Hernández I, Bianchi M, Andrighetti F, Molina C.
González M, et al.
Rev Med Chil. 1992 May;120(5):545-51.
Rev Med Chil. 1992.
PMID: 1343068
Clinical Trial.
Spanish.
Assuming that the pathogenesis of intrahepatic cholestasis of pregnancy (ICP) is related with increased estrogen levels, we studied the effects of epomediol in this disease. Patients hospitalized due to ICP received epomediol 900 mg/day (n = 7), or 1,200 mg/day (n = …
Assuming that the pathogenesis of intrahepatic cholestasis of pregnancy (ICP) is related with increased estrogen levels, we studied the effe …